Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Biowatch
Home
>
Biowatch
United Therapeutics Acquires Thymmune, Betting 460 Billion Won on Thymus Cell Therapy
The race to develop regenerative cell therapies for an ultra-rare disease that leaves patients born without a thymus—making them highly vulnerable to...
07/12/2026, 07:28 ET
Considering Wegovy for Weight Loss? South Korea's Drug Safety Ministry Warns It Is Not for Everyone
South Korea’s Ministry of Food and Drug Safety issued a strong warning on July 8 against the misuse and abuse of GLP-1 class anti-obesity...
07/12/2026, 06:56 ET
ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients
South Korean platform biotech company ABL Bio announced that development remains firmly on track despite investor...
07/12/2026, 06:48 ET
MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem
South Korean biotechnology company MediPost has entered full-scale Phase 3 clinical testing in the United States for...
07/12/2026, 01:39 ET
Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio
Novartis is significantly expanding its oncology portfolio after securing an antibody-drug conjugate technology...
07/12/2026, 01:37 ET
GC Biopharma to Conduct Phase 3 Clinical Trial for Two-Dose Chickenpox Vaccine in South Korea
GC Biopharma’s chickenpox vaccine, Barycela Inj., is set to enter a Phase 3 clinical trial in South Korea to confirm...
07/06/2026, 03:44 ET
Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo
Daewoong Pharmaceutical’s proprietary type 2 diabetes treatment, Enblo (active ingredient: enavogliflozin), is set to...
07/06/2026, 03:44 ET
Celltrion Secures Historic FDA Interchangeability Status for Truxima
Celltrion announced on the 1st that the U.S. Food and Drug Administration has granted interchangeable status to Truxima...
07/06/2026, 03:44 ET
Fueling the Future of Biohealth: InterBiz Forum Opens in Jeju With a Record 1,500 Tech Deals
The 24th InterBiz Bio Partnering & Investment Forum 2026, a premier biohealth technology deal-making event, opened...
07/06/2026, 03:43 ET
Dongkook Pharmaceutical Secures 39 Billion Won Latin American Export Deal for BPH Treatment Uresco
Waking up frequently at night to urinate or noticing a weaker urine stream is a common health concern for men as they...
07/06/2026, 00:31 ET
Previous
11
12
13
14
15
Next